Nevro Corp develops and sells medical devices mainly in the United States. Its main product is the Senza system which is intended to relieve leg and spinal cord pain with the application of the HF10 therapy.
Stock Price Prediction
Update at 5:00pm EST
140.579 - 141.137
141.137 - 141.618
135.837 - 136.526
136.526 - 137.119
138.469 - 139.594
139.594 - 140.564
as of: 2020-02-14 4:31:14 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.NVRO has closed below upper band by 25.3%. Bollinger Bands are 41.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to NVRO's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
2020-02-16 US company provided kickbacks to doctors in Switzerland US medical device company Nevro promised to pay doctors in Switzerland if they used the company’s spinal cord stimulation system.
2020-02-14 Nevro : Annual Statement of Changes in Beneficial Ownership | MarketScreener FORM 5 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1. [… | February 15, 2020
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.